HepaXen

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHepaXen
Drug Alias NameHBV vaccine (Xenetic Biosciences/Serum Institute of India)HBV vaccine (Lipoxen/Serum Institute of India)
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited KingdomIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXenetic Biosciences (Uk) Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSerum Institute Of India Pvt LtdXenetic Biosciences (Uk) Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A